Eli Lilly (LLY) Cash & Current Investments (2009 - 2026)
Eli Lilly (LLY) reported Cash & Current Investments of $8.95 billion for Q2 2026, up 152.4% from $3.55 billion a year earlier and up 69.4% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly posted Cash & Current Investments of $7.27 billion, up 112.3% from FY2024.
- Cash & Current Investments has increased for three consecutive years, with a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $3.42 billion in FY2024 (+16.9%), $2.93 billion in FY2023 (+32.4%), $2.21 billion in FY2022 (-43.4%) and $3.91 billion in FY2021 (+6.2%).
- Five-year quarterly Cash & Current Investments spans a low of $2.21 billion in Q4 2022 and a high of $9.91 billion in Q3 2025.
- Year over year, Cash & Current Investments has now increased in each of the last nine quarters, with growth averaging 74.8% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2025 (growth of 181.8%); the low point was Q4 2022 (a decline of 43.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.28 billion (Q1 2026), $7.27 billion (Q4 2025) and $9.91 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 7.85 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.95 Bn |
| Mar 31, 2026 | 5.28 Bn |
| Dec 31, 2025 | 7.27 Bn |
| Sep 30, 2025 | 9.91 Bn |
| Jun 30, 2025 | 3.55 Bn |
| Mar 31, 2025 | 3.22 Bn |
| Dec 31, 2024 | 3.42 Bn |
| Sep 30, 2024 | 3.52 Bn |
| Jun 30, 2024 | 3.36 Bn |
| Mar 31, 2024 | 2.59 Bn |
| Dec 31, 2023 | 2.93 Bn |
| Sep 30, 2023 | 2.49 Bn |
| Jun 30, 2023 | 2.83 Bn |
| Mar 31, 2023 | 3.67 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 2.74 Bn |
| Jun 30, 2022 | 2.74 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 3.91 Bn |
| Sep 30, 2021 | 3.83 Bn |
API Access
Eli Lilly Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();